A novel disease-modifying antirheumatic drug that inhibits NF-kappaB (NF-kappaB) p65 subunit (RelA) phosphorylation and nuclear translocation without affecting IKBalpha degradation.
Molecular Weight:
374.4
Purity:
>98% (HPLC)
CAS Number:
[123663-49-0]
Formula:
C17H14N2O6S
Target:
COX-2|MIF
* VAT and and shipping costs not included. Errors and price changes excepted